David Young

PCSA

David Young serves as director, officer: Pres. Research & Development at Processa Pharmaceuticals, Inc. (PCSA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

12 trades

$373.0K

Total Sells

1 trades

$2.2K

Net Position

Net Buyer

$370.8K

Companies Traded

PCSA

Active Period

Jun 2021 – Jun 2026

13 total trades

Most Recent

Buy PCSA

Jun 1, 2026 · $4.6K

David Young's Insider Trading at Processa Pharmaceuticals, Inc. (PCSA)

Buys

12 · $373.0K

Sells

1 · $2.2K

Total Shares Bought

303,892

Total Shares Sold

5,345

PCSA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 1, 2026	Buy	1,786	$2.57	$4.6K	17,131
May 19, 2026	Buy	1,545	$2.97	$4.6K	15,345
May 1, 2026	Buy	1,706	$2.69	$4.6K	13,813
Apr 17, 2026	Buy	1,545	$2.97	$4.6K	12,107
Apr 1, 2026	Buy	1,810	$2.54	$4.6K	10,562
Apr 1, 2025	Sell	5,345	$0.41	$2.2K	0
Jan 29, 2025	Buy	124,500	$0.80	$99.3K	205,405
Feb 8, 2024	Buy	21,000	$2.45	$51.5K	79,387
Feb 7, 2024	Buy	20,000	$2.53	$50.5K	58,387
Jun 12, 2023	Buy	40,000	$0.80	$32.0K	470,424
Apr 14, 2023	Buy	20,000	$0.55	$11.0K	430,424
Apr 13, 2023	Buy	60,000	$0.48	$29.0K	410,424
Jun 23, 2021	Buy	10,000	$7.67	$76.7K	345,190